[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=09bc7ce0d63798e6e9b20c7be4bf5cb8331c6c8213792335333eb24a0b47afc3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752165600,
      "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "id": 135952253,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=09bc7ce0d63798e6e9b20c7be4bf5cb8331c6c8213792335333eb24a0b47afc3"
    }
  },
  {
    "ts": null,
    "headline": "Anal Cancer Market Research Report 2025-2035 with Competitive Profiles of Incyte, BioMimetix, Bristol Myers Squibb, and AstraZeneca",
    "summary": "Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual behaviors. Symptoms encompass rectal bleeding, pain, and changes in bowel habits. Early detection through HPV vaccination and screenings is vital, yet challenges persist due to limited early detection protocols. The market is expanding, driven by rising HPV cases and advancements in immunotherapy and c",
    "url": "https://finnhub.io/api/news?id=b20121b66adb1d919cdf559b363cf06bb42cfe08ebe1e574cccd85875689e6dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752154980,
      "headline": "Anal Cancer Market Research Report 2025-2035 with Competitive Profiles of Incyte, BioMimetix, Bristol Myers Squibb, and AstraZeneca",
      "id": 135853400,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual behaviors. Symptoms encompass rectal bleeding, pain, and changes in bowel habits. Early detection through HPV vaccination and screenings is vital, yet challenges persist due to limited early detection protocols. The market is expanding, driven by rising HPV cases and advancements in immunotherapy and c",
      "url": "https://finnhub.io/api/news?id=b20121b66adb1d919cdf559b363cf06bb42cfe08ebe1e574cccd85875689e6dd"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Harvesting Portfolio Week 227: $22,700 Allocated, $2,385.24 In Projected Dividends",
    "summary": "The Dividend Harvesting Portfolio hit new all-time highs in value, profitability, and forward income. Learn more about the portfolio here.",
    "url": "https://finnhub.io/api/news?id=f4e0f7b906063acf48d8e06b320501bbedc8b36d9877b078ea79d11209334868",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752137100,
      "headline": "Dividend Harvesting Portfolio Week 227: $22,700 Allocated, $2,385.24 In Projected Dividends",
      "id": 135850527,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810162/image_1445810162.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "The Dividend Harvesting Portfolio hit new all-time highs in value, profitability, and forward income. Learn more about the portfolio here.",
      "url": "https://finnhub.io/api/news?id=f4e0f7b906063acf48d8e06b320501bbedc8b36d9877b078ea79d11209334868"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb: Hidden Facts Blur The Strength Of The Company",
    "summary": "Bristol Myers Squibb is undervalued despite challenges. Learn how BMY stock's strong pipeline, cash flow, and growth strategies offset patent expiries.",
    "url": "https://finnhub.io/api/news?id=31c55f571a0bffdfead9a7879daf4f4f25f4a0f129687ebfdfdfb89ecc027173",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752116478,
      "headline": "Bristol Myers Squibb: Hidden Facts Blur The Strength Of The Company",
      "id": 135843450,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160008492/image_2160008492.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol Myers Squibb is undervalued despite challenges. Learn how BMY stock's strong pipeline, cash flow, and growth strategies offset patent expiries.",
      "url": "https://finnhub.io/api/news?id=31c55f571a0bffdfead9a7879daf4f4f25f4a0f129687ebfdfdfb89ecc027173"
    }
  }
]